各種ルーチンから、ワックスへの組織処理、単一およびマルチプレックス免疫組織化学(IHC)/免疫蛍光(IF)、スライドスキャン、画像分析など、特殊なプロジェクトにも対応する高度な組織学的メソッドを提供しています。
Areas of expertise
- Immunology
- Immuno-oncology
- Fibrosis
- Neuroscience
Staining approaches
Staining approaches provided by Concept Life Sciences Histology include:
- Staining dyes
e.g., H&E, Alcian blue, Picrosirius red - Single and multiplex chromogenic immunohistochemistry (IHC)
e.g., DAB, red, green - Single and multiplex immunofluorescence (IF)
up to 8-plex (9-colour incl. DAPI) - RNAscope
mRNA detection; up to 4-plex - Mixed multiplex detection
IHC/IF (protein) + RNAscope (mRNA)
Our use of the latest laboratory equipment, including the Leica BOND RX Research Stainer and Vectra PolarisTM imaging system enables us to fully automate many of our staining approaches enabling us to deliver a robust, reliable, and high-throughput service.
Staining dye
![]() H&E (human NSCLC) | Staining dye
![]() Alcian blue (human colon) | Chromogenic IHC
![]() CD3, Haematoxylin (human NSCLC) |
2-plex IHC
![]() CD8, CD31, Haematoxylin (mouse spleen) | IF![]() CD8, DAPI (human NSCLC) | 2-plex IF
![]() PanCK, C4d, DAPI (mouse kidney) |
3-plex IF
![]() CD68, CD8, PanCK, DAPI (human tonsil) | 4-plex IF
![]() PD-L1, PD-1, CD4, CD8, DAPI (human tonsil) | RNAscope![]() POLR2A, DAPI (HeLa cells) |
8-plex (9-colour) IF

Concept Life Sciences Histology offers simultaneous imaging of up to 8 markers (proteins) + DAPI (nuclear stain) on a single tissue section. This can provide morphological, pathological, and spatial information of the juxtaposition of different cell types, which can be quantified by image analysis.
Image right: CD3, CD8, CD4, FoxP3, CD68, Ki67, PanCK, DAPI with OpalTM Multiplex Detection Reagents imaged using the Vectra PolarisTM from PerkinElmer (human CRC)
Tissue biomarkers

Specialized IHC staining approaches utilized during preclinical and clinical drug discovery research provide valuable insights into the location and positioning of biomarkers (cell types) within tissue.
Our knowledge, expertise and pragmatic approach to antibody selection and validation can facilitate demonstration of novel and challenging biomarkers in situ, providing high-value data.
Image right: Human tonsil - T cells (CD3), Cytotoxic T cells (CD8), Regulatory T cells (FoxP3), Myeloid cells (CD68), Epithelial cells (PanCK), Proliferating cells (Ki67), Nuclei (DAPI)